Načítá se...
RADI-04. COMBINED RADIOLOGICAL, PATHOLOGICAL AND MOLECULAR OUTCOME EVALUATION IN NEWLY DIAGNOSED NON-BRAINSTEM PEDIATRIC HIGH-GRADE GLIOMA FROM THE RANDOMIZED, MULTICENTER HERBY PHASE II TRIAL
INTRODUCTION: The HERBY trial assessed the efficacy of adding Bevacizumab (BEV) to postoperative radiotherapy/temozolamide (RT/TMZ) in children with newly diagnosed non-pontine high-grade gliomas (HGG). The trial showed no difference in OS or EFS between BEV and non-BEV treatment arms. METHODS: Radi...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6012169/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.644 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|